New Enterprise Associates 15, L.P. → Eargo, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Eargo, Inc.

Filed	Form	Filer	Stake	Shares
2021-04-28	SC	Gilde Healthcare Holding B.V.	—	—	view →
2021-04-26	SC	Longitude Capital Partners IV, LLC	—	—	view →

Other Filings by New Enterprise Associates 15, L.P.

Filed	Form	Issuer	Stake	Shares
2025-03-10	SCHEDULE	Senti Biosciences, Inc. SNTI	14.50%	3,775,615	view →
2024-10-08	SC	OnKure Therapeutics, Inc. OKUR	—	—	view →
2021-04-13	SC	Millendo Therapeutics, Inc. TPST	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →